• Home
• About
• Log In
• Register
• Search
• Current
• Archives
• Sample Papers
• Submit
• Subscribe

The biotechnology industry is in constant flux. Legal and political rulings can impact the commercial potential of scientific applications; changes in public markets can influence which business models are likely to receive funding; and, regulatory decisions can influence operations from research through licensing.

Regular developments in these diverse areas mean that the biotechnology industry is always changing. To make matters more complicated, few people entering the industry received exposure to all these areas in their training, and there are no formal requirements for continuing education.

Self-directed continuing education is therefore a pressing need for industry practitioners. How can one hope to keep abreast of all these changes? Continuing education is essential in biotechnology.

Let the Journal of Commercial Biotechnology, with its focus on the business of biotechnology, help train your new hires team, keep your existing team on the cutting edge, or add a valuable compenent to your conference.

By tapping its diverse and highly esteemed network of editorial board members and authors, the Journal of Commercial Biotechnology is able to assemble a bootcamp customized to your specific needs.

Available modules include:

• Global Biotechnology
• Business Planning
• Intellectual Property
• Reimbursement
• Finance
• Policy
• Commercial Strategy
• Licensing
• Valuation

For more information contact the Journal of Commercial Biotechnology's editor, Yali Friedman, Ph.D. at editor@commercialbiotechnology.com .